MultivisionDx
MultivisionDx builds AI-powered decision-support tools for personalized diagnosis and treatment selection for solid cancer.
MultivisionDx has raised €1.0M across 1 funding round from 4 investors, most recently a Pre-Seed round in Dec 2025. Based in Helsinki, Finland; active in AI. Data as of 28 Oct 2026.
Helsinki, Finlandwww.multivision.ai ↗
Total raised
€1.0M
€1,000,000
Funding rounds
1
Investors
4
distinct backers
Active since
2025-12
latest 2025-12
Funding by year
EUR raised per yearMultivisionDx — funding by year — interactive chart.
Data table
| MultivisionDx — funding by year | |
|---|---|
| 2025 | €1.0M |
Signals
High confidenceRaise-next likelihood32
base rate 24% for Pre-Seed
- ▲ In typical raise window
- ▼ Low backer re-investment
Timing: in window vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2025-12-03 | Pre-Seed | €1.0M | angel investor,Antler,Helsinki University Funds,Kaikarhenni Oy | View deal → |
Investors
4Related news
Similar companies
same sector or country- Mistral AI€6.5BFrance · AI
- Helsing€2.9BGermany · AI
- UiPath€1.7BRomania · AI
- Iceye€1.5BFinland · Space
- ElevenLabs€1.2BUK · AI
- Ineffable Intelligence€936MUK · AI
Global coverage: FundingData